{"id":"https://openalex.org/W2621557729","doi":"https://doi.org/10.1002/hon.2437_4","title":"CRISPR\u2010CAS9 GENETIC SCREENS UNCOVER A B CELL RECEPTOR\u2010MYD88 SUPERPATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA","display_name":"CRISPR\u2010CAS9 GENETIC SCREENS UNCOVER A B CELL RECEPTOR\u2010MYD88 SUPERPATHWAY IN DIFFUSE LARGE B CELL LYMPHOMA","publication_year":2017,"publication_date":"2017-06-01","ids":{"openalex":"https://openalex.org/W2621557729","doi":"https://doi.org/10.1002/hon.2437_4","mag":"2621557729"},"language":"en","primary_location":{"id":"doi:10.1002/hon.2437_4","doi":"https://doi.org/10.1002/hon.2437_4","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.2437_4","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.2437_4","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.2437_4","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083253919","display_name":"Ryan M. Young","orcid":"https://orcid.org/0000-0003-0706-8019","observed_orcids":["https://orcid.org/0000-0003-0706-8019","https://orcid.org/0000-0002-5866-6126"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R.M. Young","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013514926","display_name":"James D. Phelan","orcid":"https://orcid.org/0000-0001-8950-2485","observed_orcids":["https://orcid.org/0000-0001-8950-2485"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J.D. Phelan","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065048859","display_name":"Dan E. Webster","orcid":"https://orcid.org/0000-0001-6874-8451","observed_orcids":["https://orcid.org/0000-0001-6874-8451"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D.E. Webster","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008532676","display_name":"Sandrine Roulland","orcid":"https://orcid.org/0000-0003-2187-1959","observed_orcids":["https://orcid.org/0000-0003-2187-1959"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Roulland","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086207316","display_name":"George W. Wright","orcid":"https://orcid.org/0000-0003-0003-0843","observed_orcids":["https://orcid.org/0000-0003-0003-0843","https://orcid.org/0009-0002-3973-0791"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G. Wright","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023278037","display_name":"Da Wei Huang","orcid":"https://orcid.org/0000-0002-6793-9966","observed_orcids":["https://orcid.org/0000-0002-6793-9966"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Huang","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073071988","display_name":"Roland Schmitz","orcid":"https://orcid.org/0000-0002-3348-6807","observed_orcids":["https://orcid.org/0000-0002-3348-6807"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Schmitz","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025942951","display_name":"Louis M. Staudt","orcid":"https://orcid.org/0000-0002-1735-2892","observed_orcids":["https://orcid.org/0000-0002-1735-2892"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L.M. Staudt","raw_affiliation_strings":["Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lymphoid Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"S2","first_page":"25","last_page":"25"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.019600000232458115,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9649999737739563},{"id":"https://openalex.org/keywords/activated-b-cell-like-dlbcl","display_name":"activated B-cell-like DLBCL","score":0.8650000095367432},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.8970000147819519},{"id":"https://openalex.org/keywords/myd88-l265p-mutation","display_name":"MYD88 L265P mutation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/tlr9","display_name":"TLR9","score":0.9860000014305115},{"id":"https://openalex.org/keywords/card11","display_name":"CARD11","score":0.9739999771118164},{"id":"https://openalex.org/keywords/malt1","display_name":"MALT1","score":0.996999979019165},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7459999918937683},{"id":"https://openalex.org/keywords/endolysosomes","display_name":"endolysosomes","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.7139999866485596},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.5299999713897705},{"id":"https://openalex.org/keywords/essential-genes","display_name":"essential genes","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.7500799894332886},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.7491285800933838},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.7298259735107422},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5987948179244995},{"id":"https://openalex.org/C157695867","wikidata":"https://www.wikidata.org/wiki/Q1100474","display_name":"B-cell receptor","level":4,"score":0.5609787702560425},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5482873320579529},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.49374493956565857},{"id":"https://openalex.org/C207177822","wikidata":"https://www.wikidata.org/wiki/Q5050812","display_name":"Genetic screen","level":4,"score":0.46225258708000183},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.44886669516563416},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.3228907585144043},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.30531615018844604},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2663915753364563},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2467156946659088},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.23079395294189453},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.21859753131866455},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.21155419945716858},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15803584456443787},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.14766603708267212},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14249059557914734},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.10607144236564636},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0688292384147644}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/hon.2437_4","doi":"https://doi.org/10.1002/hon.2437_4","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.2437_4","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.2437_4","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1002/hon.2437_4","doi":"https://doi.org/10.1002/hon.2437_4","is_oa":true,"landing_page_url":"https://doi.org/10.1002/hon.2437_4","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.2437_4","source":{"id":"https://openalex.org/S23714410","display_name":"Hematological Oncology","issn_l":"0278-0232","issn":["0278-0232","1099-1069"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematological Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.4300000071525574}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2621557729.pdf","grobid_xml":"https://content.openalex.org/works/W2621557729.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2025198947","https://openalex.org/W2809201980","https://openalex.org/W3217152561","https://openalex.org/W7165947769","https://openalex.org/W6943782917","https://openalex.org/W2326263722","https://openalex.org/W2237979725","https://openalex.org/W2671474439","https://openalex.org/W2336620963","https://openalex.org/W2610825338"],"abstract_inverted_index":{"Introduction:":[0],"The":[1],"activated":[2],"B":[3,11,21],"cell":[4,12,22,117,160],"like":[5],"(ABC)":[6],"subtype":[7],"of":[8,28,34,53,57,110,281,290,305,369,372,389],"diffuse":[9,421],"large":[10,422],"lymphoma":[13,424],"(DLBCL)":[14],"frequently":[15],"relies":[16],"on":[17,172,256,318,381],"signaling":[18,89,112,194,327,337,350,373],"from":[19],"the":[20,58,85,133,151,174,208,222,242,282,291,294,306,319,331,367,378,402],"receptor":[23,155,419],"(BCR)":[24],"and":[25,79,87,129,179,195,201,212,227,278,312,321,351,364,377,413],"mutant":[26,177],"isoforms":[27],"MYD88":[29,78,88,153,175,213,243,271,300,326,336,376,414],"to":[30,38,107,125,138,167,186,246,342,384,405],"maintain":[31],"oncogenic":[32,387],"levels":[33],"NF-\u03baB":[35,349,390],"activity":[36],"essential":[37],"its":[39],"survival.":[40],"These":[41,81,345,394],"pathways":[42,90],"are":[43,114],"commonly":[44],"mutated":[45],"in":[46,63,70,76,103,142,157,204,233,264,273,309,328,338,391,407],"ABC":[47,71,159,168,205,265,310,392,408],"DLBCL.":[48,393],"A":[49],"recent":[50],"clinical":[51,82],"trial":[52],"ibrutinib,":[54],"an":[55],"inhibitor":[56],"BCR":[59,86,111,182,193,219,226,320],"proximal":[60],"kinase":[61],"BTK,":[62],"relapsed/refractory":[64],"DLBCL":[65,72,105],"patients":[66,73],"reported":[67],"exceptional":[68],"responses":[69,404],"co-expressing":[74],"mutations":[75],"both":[77,173],"CD79B.":[80],"data":[83],"suggested":[84],"may":[91],"be":[92],"functional":[93],"coupled.":[94],"Methods:":[95],"We":[96,197,334,360],"performed":[97],"genome-wide":[98],"CRISPR-Cas9-based":[99],"lethality":[100],"(dropout)":[101],"screens":[102,147],"8":[104],"lines":[106],"discover":[108],"modulators":[109],"that":[113,170,199,252,270,286,298,313,362,410],"required":[115,156],"for":[116],"viability":[118],"or":[119],"proliferation.":[120],"Essential":[121],"genes":[122],"were":[123,316,352],"subjected":[124],"further":[126],"genetic,":[127],"biochemical":[128],"image":[130],"analysis,":[131],"including":[132,375],"proximity":[134],"ligation":[135],"assay":[136],"(PLA)":[137],"visualize":[139],"protein-protein":[140],"interactions":[141,315],"situ.":[143],"Results:":[144],"Our":[145],"CRISPR":[146],"identified":[148],"TLR9":[149,200,211,228,363],"as":[150],"only":[152],"binding":[154],"MYD88-mutant":[158],"lines.":[161,206],"Surprisingly,":[162],"this":[163,260],"requirement":[164],"was":[165,262,272],"limited":[166],"models":[169],"relied":[171],"L265P":[176,214,244,415],"isoform":[178,245],"chronic":[180,191],"active":[181,192,218,348],"signaling,":[183],"leading":[184],"us":[185],"explore":[187],"a":[188,248,370,398],"link":[189],"between":[190,210],"TLR9.":[196,322],"found":[198],"IgM":[202,365],"co-immunoprecipitate":[203],"Moreover,":[207],"association":[209,229,275],"is":[215,287],"dependent":[216,317],"upon":[217],"signaling.":[220],"Using":[221],"PLA,":[223,295],"we":[224,240,267,296,324],"visualized":[225,325],"with":[230,276,302,357],"each":[231],"other":[232],"Lamp1+":[234,343],"endolysosomes.":[235],"To":[236],"advance":[237],"these":[238,314],"findings,":[239],"fused":[241],"BioID2,":[247],"promiscuous":[249],"biotin":[250,255],"ligase":[251],"will":[253],"attach":[254],"neighboring":[257],"proteins.":[258],"When":[259],"construct":[261],"expressed":[263],"DLBCLs,":[266],"unexpectedly":[268],"observed":[269,335],"close":[274],"CARD11":[277],"MALT1,":[279],"components":[280],"CBM":[283,307,379],"adapter":[284],"complex":[285,308,380],"assembled":[288],"downstream":[289],"BCR.":[292],"Employing":[293],"show":[297],"endogenous":[299],"interacts":[301],"all":[303],"members":[304],"lines,":[311],"Finally,":[323],"cells":[329],"expressing":[330],"MYD88-L265P-BioID2":[332],"construct.":[333],"large-scale":[339],"complexes":[340,346],"juxtaposed":[341],"vesicles.":[344],"contained":[347],"disrupted":[353],"by":[354],"BTK":[355],"inhibition":[356],"ibrutinib.":[358],"Conclusions:":[359],"demonstrate":[361],"facilitate":[366],"assembly":[368],"superpathway":[371],"adapters":[374],"endolysosomal":[382],"membranes":[383],"cooperatively":[385],"drive":[386],"activation":[388],"supercomplexes":[395],"apparently":[396],"create":[397],"hyperaddiction":[399],"phenotype":[400],"given":[401],"frequent":[403],"ibrutinib":[406],"tumors":[409],"harbor":[411],"CD79B":[412],"mutations.":[416],"Keywords:":[417],"B-cell":[418,423],"(BCR);":[420],"(DLBCL);":[425],"MYD88.":[426]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-06-15T00:00:00"}